10.29MMarket Cap-2500P/E (Static)
0.005High0.005Low251.96KVolume0.005Open0.004Pre Close1.26KTurnover0.01052wk High0.02%Turnover Ratio2.06BShares0.00352wk Low-0.002EPS TTM6.95MFloat Cap0.619Historical HighLossP/E (Static)1.39BShs Float0.003Historical Low-0.002EPS LYR0.00%Amplitude--Dividend TTM2.50P/B1Lot Size--Div YieldTTM
Patrys Ltd Stock Forum
Delivery of GENE-EDITING constructs could be very lucrative for PAB . Something not priced in the share price regarding future potential.
Comment by PAB in 2022
Patrys could also become a pioneer in the emerging gene-editing
payload delivery space, giving it a lead in the gene therapy space, which is expected to see
1,500% growth by 2027, he added.
No comment yet